HESTER: A Phase II Study Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion in Pediatric and Young Adult Patients with Acute Lymphoblastic Leukemia Experiencing Loss of B-Cell Aplasia
Michael W. Boyer(University of Utah), Jennifer Willert(Unknown), Kara L. Davis(Stanford Medicine), Samuel John(Southwestern Medical Center), Gary Douglas Myers(Baylor College of Medicine), Andrea Magley, Amy K. Keating(Boston Children's Hospital), Christina Kovacs, Sonali Chaudhury(Northwestern University), Stephan A. Grupp(Children's Hospital of Philadelphia), Julie‐An Talano(Dana-Farber Cancer Institute), Timothy A. Driscoll(Duke Medical Center), Christine L. Phillips(Cincinnati Children's Hospital Medical Center), Michelle L. Hermiston(VinUniversity), Das Purkayastha, Michael A. Pulsipher(Primary Children's Hospital)
Cited by 8
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k